EFFECT OF SUSTAINED-RELEASE ON THE PHARMACOKINETICS OF VALPROIC ACID IN THE DOG

被引:7
作者
BIALER, M
FRIEDMAN, M
DUBROVSKY, J
机构
关键词
D O I
10.1016/0378-5173(84)90217-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:53 / 63
页数:11
相关论文
共 23 条
[1]  
BALLARD BE, 1978, SUSTAINED CONTROLLED, P1
[2]   COMPARATIVE PHARMACOKINETIC ANALYSIS OF A NOVEL SUSTAINED-RELEASE DOSAGE FORM OF VALPROIC ACID IN DOGS [J].
BIALER, M ;
FRIEDMAN, M ;
DUBROVSKY, J .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (01) :1-10
[3]  
BIALER M, 1984, J PHARM SCI
[4]   VALPROIC ACID DOSAGE AND PLASMA-PROTEIN BINDING AND CLEARANCE [J].
BOWDLE, TA ;
PATEL, IH ;
LEVY, RH ;
WILENSKY, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :486-492
[5]   VALPROIC ACID - REVIEW OF A NEW ANTIEPILEPTIC DRUG [J].
BRUNI, J ;
WILDER, BJ .
ARCHIVES OF NEUROLOGY, 1979, 36 (07) :393-398
[6]  
CENRAUD B, 1981, ADV EPILEPTOL, P549
[7]  
Gibaldi M, 1982, PHARMACOKINETICS REV, V2nd, P45
[8]   DISPOSITION OF VALPROIC ACID IN MAN [J].
GUGLER, R ;
SCHELL, A ;
EICHELBAUM, M ;
FROSCHER, W ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (02) :125-132
[9]   CLINICAL PHARMACOKINETICS OF VALPROIC ACID [J].
GUGLER, R ;
UNRUH, GEV .
CLINICAL PHARMACOKINETICS, 1980, 5 (01) :67-83
[10]  
KLOTZ U, 1982, INT J CLIN PHARM TH, V20, P24